Its levels in atherosclerotic lesions of both humans and rabbits were shown to be extremely low, while overexpression of NOX1 was observed in patients with cardiovascular disease or diabetes mellitus [46,47]. This evidence concerns the gene NOX1 and diabetes mellitus.